Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Looking for low annual fee credit cards for travel? Explore options to save money and enhance your travel experience.
18,244 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
An international investigation ties a fentanyl-linked chinese network tied to a Japan-based crypto scam to a counterf...
A seemingly routine DoorDash support call turned into a financial nightmare for a driver. This is how the doordash or...
Traders are testing 0DTE covered calls on three major index ETFs to generate daily income. This report outlines the a...
Is Lilly stock undervalued healthcare? This article breaks down the valuation case, growth catalysts, risks, and a pr...
World Cup bets on Polymarket surged to $3.3 billion in trading volume, eclipsing the Super Bowl and drawing attention...
China’s private space sector has exploded from a handful of startups to hundreds of firms. This rising ecosystem prom...
Investors are buzzing about Micron Technology as AI and data-center demand shift the memory market. This article expl...
The ITA ETF just ripped higher again, underscoring a multi-year upcycle in America’s rearmament push. Here’s what inv...
The GLP-1 wave has traders buzzing. While Lilly and Novo Nordisk hold steady as reliable bets, smart portfolios tap i...
SK hynix prepares to begin trading on Nasdaq with ADRs priced at $149, in a move that broadens access to AI memory ex...
Elon Musk and Sam Altman trade public jabs over who should lead the AI investment story. The clash is fueling investo...